Stockreport

FDA to restrict GLP-1 ingredients used in non-approved compounded drugs [CNBC]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF The U.S. Food and Drug Administration said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs that companies such as Hims & Hers and [Read more]